Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2007 by National Cancer Institute (NCI).
Recruitment status was  Recruiting
Study NCT00458796   Information provided by National Cancer Institute (NCI)

First Received on April 9, 2007.   Last Updated on August 5, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Hypercalcemia of Malignancy
Metastatic Cancer
Musculoskeletal Complications
Pain
Additional conditions recognized in this trial
Breast Neoplasms
Hypercalcemia
Neoplasm Metastasis
Neoplasms
Neoplasms, Second Primary
More general conditions related to this trial
Breast Diseases
Calcium Metabolism Disorders
Metabolic Diseases
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Skin Diseases
Water-Electrolyte Imbalance
Interventions listed in this trial
zoledronic acid
quality-of-life assessment
Additional drug interventions recognized in this trial
Diphosphonates
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of Leeds


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services